ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
97 033,08
-0,18%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Theravance Biopharma Inc (TBPH)

  7. Theravance Biopharma Inc (TBPH) Actualités

TBPH

Theravance Biopharma (TBPH)

Theravance Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TBPH
DateHeureSourceTitreSymboleSociété
17/12/202412h00PR Newswire (US)Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare ConferenceNASDAQ:TBPHTheravance Biopharma Inc
23/11/202400h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
20/11/202412h00PR Newswire (US)Theravance Biopharma to Participate in an Upcoming Investor ConferenceNASDAQ:TBPHTheravance Biopharma Inc
14/11/202415h53Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TBPHTheravance Biopharma Inc
14/11/202412h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBPHTheravance Biopharma Inc
12/11/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBPHTheravance Biopharma Inc
12/11/202422h05PR Newswire (US)Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder ValueNASDAQ:TBPHTheravance Biopharma Inc
24/10/202412h00PR Newswire (US)Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024NASDAQ:TBPHTheravance Biopharma Inc
18/10/202415h00PR Newswire (US)Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary DiseaseNASDAQ:TBPHTheravance Biopharma Inc
05/08/202422h05PR Newswire (US)Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TBPHTheravance Biopharma Inc
22/07/202412h00PR Newswire (US)Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024NASDAQ:TBPHTheravance Biopharma Inc
11/06/202422h17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TBPHTheravance Biopharma Inc
13/05/202422h05PR Newswire (US)Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TBPHTheravance Biopharma Inc
29/04/202412h00PR Newswire (US)Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024NASDAQ:TBPHTheravance Biopharma Inc
10/04/202412h00PR Newswire (US)Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024NASDAQ:TBPHTheravance Biopharma Inc
26/02/202422h05PR Newswire (US)Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:TBPHTheravance Biopharma Inc
17/02/202402h12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TBPHTheravance Biopharma Inc
14/02/202422h00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TBPHTheravance Biopharma Inc
14/02/202412h00PR Newswire (US)Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024NASDAQ:TBPHTheravance Biopharma Inc
05/01/202412h00PR Newswire (US)Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)NASDAQ:TBPHTheravance Biopharma Inc
21/12/202323h10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TBPHTheravance Biopharma Inc
21/12/202323h00PR Newswire (US)Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of DirectorsNASDAQ:TBPHTheravance Biopharma Inc
18/12/202312h00PR Newswire (US)Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare ConferenceNASDAQ:TBPHTheravance Biopharma Inc
16/11/202312h00PR Newswire (US)Theravance Biopharma to Present New Ampreloxetine Data at the 34th International Symposium on The Autonomic Nervous SystemNASDAQ:TBPHTheravance Biopharma Inc
15/11/202312h00PR Newswire (US)Theravance Biopharma to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:TBPHTheravance Biopharma Inc
13/11/202314h00PR Newswire (US)Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)NASDAQ:TBPHTheravance Biopharma Inc
07/11/202322h28PR Newswire (US)Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TBPHTheravance Biopharma Inc
19/10/202312h00PR Newswire (US)Theravance Biopharma to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:TBPHTheravance Biopharma Inc
16/10/202322h13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TBPHTheravance Biopharma Inc
28/08/202312h05PR Newswire (US)Theravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson's Disease and Movement DisordersNASDAQ:TBPHTheravance Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:TBPH

Dernières Valeurs Consultées

TG
A19YHY
Fairfax Financial
HITB
PBTTBTC
Purple Butterfly Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés